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• Some phase III clinical trials were done with onconase in humans, 
showing an increase of median survival of the patients in comparison 
to the standard chemotherapeutic agent8,9.   
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Autophagy 
• Dual role of autophagy. Pro-
survival and pro-death1. 
• Autophagic cell death 
(Programmed Cell Death type II). 
Autophagy inhibitors rescue the cell 
from death.  
• Promising new pathway to 
develop antitumoral drugs.  
 
Antitumoral ribonucleases 
• Members of the RNase A superfamily. Small and 
cationic secretion ribonucleases. 
• Degradation of the cell RNA triggers cell death. 
• They enter specifically cancer cells due to the anionic 
properties of their membrane. 
• Autophagic cell death has been reported to be 
induced by the two main antitumour ribonucleases2,3,4.  
      Bovine Seminal RNase (BS-RNase) 
      Bullfrog RNase (onconase) 
Objectives 
• In basis of RNase L autophagy 
induction5, to propose an hypothetical 
mechanism of induction of 
autophagic cell death in tumoral cells 
for vertebrate secreted cytotoxic 
RNases.  
• To evaluate the future of cytotoxic 
ribonucleases as antitumoral agents.  
Introduction 
Induction mechanism of autophagic cell death by ribonucleases 
Structural determinants of the antitumoral activity of vertebrate secretory RNases 
• Cationic properties.  
• Ability of entering cells7. 
• Evasion of ribonuclease inhibitor. Specific for RNase A superfamily. 
        Suppression of RI-interacting residues (onconase).  
        Multimer formation (BS-RNase). 
Conclusions 
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BS-RNase 
WT2 
BS-RNase 
G38K2 
Onconase3 Cell  
type 
 
IC50 
~100 μg/ml ~18 μg/ml ~22 μg/ml Pancreatic cancer cells 
> 200 μg/ml ~200 μg/ml > 200 μg/ml Fibroblasts 
Cell growth  
inhibition at 50 μg/ml 
~ 40 % ~75 % ~ 62.5% Pancreatic cancer cells 
~ 17 % ~ 25 % ~ 30 % Fibroblasts 
Cell growth  
inhibition at 200 μg/ml 
~ 60 % ~ 80 % ~ 65 % Pancreatic cancer cells 
~ 40 % ~ 50 % ~ 35 % Fibroblasts 
Autophagosome  
formation at 200 μg/ml 
13x 35x 4x Pancreatic cancer cells 
3x 4x 1.5x Fibroblasts 
Reported antitumoral activities of cytotoxic RNases 
Antitumoral activity improvement 
• Enhancement of catalytic activity will result in higher antitumoral activity. 
• Enhancement of cationic properties results in better selectivity to cancer cells.  
• Higher molecular weight (multimers) would reduce the high renal 
accumulation and the rapid clearance from blood circulation found in clinical 
trials.  
• Enhancement of the stability of BS-RNase dimer for RI avoidance. 
• Ongoing studies (Quintessence Biosciences): Some mutants of HP-RNase 
(EvadeTM Ribonucleases) are able to evade RI and target cancer cells more 
specifically.  
 
RNase L 
• Antiviral non-secretory 
RNase linked to innate 
immunity. 
 
• Autophagy induction 
by RNase L was reported 
in response to viral 
infections5. 
  
Onconase 
BS-RNase 
? 
Abbreviations: Atg (Autophagy related); Bcl-2 (B-cell lymphoma 2); Beclin1 (BCL-2 interacting myosin/moesin-like coiled-coil protein 1); DFCP1 (double FYVE domain-containing protein 1); JNK (c-Jun N-terminal kinase); PKR (dsRNA-dependant protein kinase); ULK (UNK-51-like kinase); Vps (vacuolar protein sorting); WIPI (WD repeat domain phosphoinositide-interacting).  
Taken and modified from Michaelis et al, 2007; Lamb et  al, 2013 
Philogenetic tree of selected members of RNAse A 
superfamily. Protein sequences  were aligned by ClustalW and 
MEGA6 was used for the construction of  the tree. 
